amlexanox has been researched along with Eosinophilia, Pulmonary in 1 studies
amlexanox: SRA-A antagonist;structure given in first source
amlexanox : A pyridochromene-derived monocarboxylic acid having an amino substituent at the 2-position, an oxo substituent at the 5-position and an isopropyl substituent at the 7-position.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ozasa, K | 1 |
| Temizoz, B | 1 |
| Kusakabe, T | 1 |
| Kobari, S | 1 |
| Momota, M | 1 |
| Coban, C | 1 |
| Ito, S | 1 |
| Kobiyama, K | 1 |
| Kuroda, E | 1 |
| Ishii, KJ | 1 |
1 other study available for amlexanox and Eosinophilia, Pulmonary
| Article | Year |
|---|---|
Cyclic GMP-AMP Triggers Asthma in an IL-33-Dependent Manner That Is Blocked by Amlexanox, a TBK1 Inhibitor.
Topics: Allergens; Aminopyridines; Animals; Asthma; Bronchoalveolar Lavage Fluid; Eosinophils; Female; Immun | 2019 |